Neurocarrus Inc
Developing long acting non-opioid chronic pain medications
* Data source: Crunchbase
- Founded
- 2017
- Employees*
- 2-10
- Funding to Date*
- $100K
- Website
- neurocarrus.com
Our success as a company would change the healthcare industry by providing an alternative to opioids as a front-line pain management solution.
More than 11 million people abused prescription opioids in 2016, and the CDC estimates it has an economic cost of $80B a year
Neurocarrus is a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control.